News Releases – 2002 ArchiveDISCLAIMER FOR ARCHIVES
The information in AstraZeneca Canada’s News Releases Archive was factually accurate on the date of publication. This information remains on our website for historical purposes only. We assume no duty to update the information to reflect subsequent developments. Readers should not rely upon this information as current or accurate after the applicable release dates.
| Dec 27, 2002 |
AstraZeneca Canada Recognized as One of Canada’s Top 50 Employers |
| Dec 11, 2002 |
Four-year Findings of Landmark Trial Point to Major Transformation in Breast Cancer Treatment Approaches |
| Oct 31, 2002 |
AstraZeneca and the American Psychiatric Association (APA) Collaborate to Recognize and Support Future Leaders in Psychiatry |
| Jun 27, 2002 |
Reducing Hypertension in the Elderly Leads to a Significant Reduction in the Incidence of Stroke |
| Jun 27, 2002 |
Three Students Recognized for Outstanding Community Service |
| Jun 21, 2002 |
Landmark Breast Cancer Study Published Today in the Lancet |
| May 21, 2002 |
AstraZeneca Announces Results For ZD1839 (Iressa™) In Advanced Head & Neck Cancer |
| May 20, 2002 |
Anastrozole (''Arimidex'') Could Ease Current Concerns for Women Taking Hormonal Treatment for Early Breast Cancer |
| May 18, 2002 |
ZD1839 (Iressa™) Final, Pivotal Study Results: Encouraging Anti-Tumour Activity Confirmed in Advanced Non-small-cell Lung Cancer |
| May 15, 2002 |
Definitive Early Breast Cancer Trial to be Presented at World's Largest Oncology Meeting |
| May 15, 2002 |
AstraZeneca Canada Inc. Makes Significant Gastrointestinal Research Investment |
| May 6, 2002 |
Lung Cancer Remains Canada's Leading Cause of Cancer Death |
| Feb 12, 2002 |
New Asthma Combination Therapy Approved by Health Canada |
|
